000 01254 a2200313 4500
005 20250515012403.0
264 0 _c20060223
008 200602s 0 0 eng d
022 _a0008-5472
024 7 _a10.1158/0008-5472.CAN-05-2053
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarlsson, Jan Olof G
245 0 0 _aThe magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
_h[electronic resource]
260 _bCancer research
_cJan 2006
300 _a598; author reply 598 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aAntineoplastic Agents
_xpharmacology
650 0 4 _aBiomimetic Materials
_xpharmacology
650 0 4 _aContrast Media
_xpharmacology
650 0 4 _aEdetic Acid
_xanalogs & derivatives
650 0 4 _aHydrogen Peroxide
_xmetabolism
650 0 4 _aPyridoxal Phosphate
_xanalogs & derivatives
650 0 4 _aSuperoxide Dismutase
_xmetabolism
700 1 _aBrurok, Heidi
700 1 _aTowart, Rob
700 1 _aJynge, Per
773 0 _tCancer research
_gvol. 66
_gno. 1
_gp. 598; author reply 598
856 4 0 _uhttps://doi.org/10.1158/0008-5472.CAN-05-2053
_zAvailable from publisher's website
999 _c16014828
_d16014828